• / Free eNewsletters & Magazine
  • / My Account
Home>Search Results

Related Content

  1. Videos
  2. Articles
  1. No Sign of Slowdown in Biotech M&A

    High levels of merger and acquisition activity will be the big theme of year for biotech, says Morningstar's Lauren Migliore.

  2. Our Top Five Biotech Acquisition Candidates

    M&A activity grew in 2010, and we expect deal volume to remain strong in 2011.

  3. How to Interpret Our CEF Analyst Ratings

    Cara Esser explains the fundamentals behind Morningstar's CEF Analyst Ratings and what investors should keep in mind before buying or selling a fund.

  4. 5 Resolutions for the Market

    Morningstar markets editor Jeremy Glaser highlights some must-dos in 2013 for banks, Blackberry devices, frazzled investors, and corporate America's balance sheets.

1
blog comments powered by Disqus
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.